TumorGlow Intraoperative Molecular Imaging (IMI)

Launched by UNIVERSITY OF PENNSYLVANIA · Jan 20, 2021

Keywords

ClinConnect Summary

The TumorGlow Intraoperative Molecular Imaging (IMI) trial is a research study designed to help doctors better see and treat solid tumors during surgery. This study is looking at how safe and effective a special imaging technique using a dye called indocyanine green is when used to guide surgeons in removing tumors. It is open to adults aged 18 and older who have solid tumors or diseased tissue that can be surgically removed and are at risk of returning after surgery. To be eligible, patients must be in good health for surgery and capable of understanding the consent process.

If you participate in this trial, you can expect to have your surgery with the assistance of this new imaging method, which could help improve the chances of removing all of the tumor while minimizing the risk of recurrence. It’s important to note that individuals who are pregnant, children, or those with certain health issues, such as uncontrolled high blood pressure or allergies to iodide, cannot take part in the study. The trial is currently recruiting participants, and your doctor can provide more information about whether this study is a good fit for you or your loved one.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients 18 years of age or older.
• • Patients presenting with any solid tumor and/or diseased tissue even benign nodules presumed to be resectable and at risk for recurrence on pre-operative assessment.
• • Good operative candidate as determined by the treating physician and/or multidisciplinary team.
• • Subject capable of giving informed consent.
• Exclusion Criteria:
• • Subject unable to participate in the consent process.
• • Vulnerable population including pregnant women, prisoners, and children.
• • History of uncontrolled hypertension (e.g., history of an ER admission for hypertensive crisis or ≥ 3 blood pressure medications)
• • Patients with a self-reported history of iodide allergies.